Ceftazidime for Injection, USP

Hazard statements (CLP)

H317, H319, H334

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

Classification of the Substance or Mixture GHS-US Classification Serious eye damage/eye irritation, Category 2A H319 Respiratory sensitization, Category 1 H334 Skin sensitization, Category 1 H317 Combustible dust

2.2 Label elements

GHS-US Labeling

Hazard pictograms

GHS08

Signal word

Danger

Hazard statements

May form combustible dust concentrations in air [if small particles are generated during further processing, handling or by other means.]. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled.

Precautionary statements

P261 - Avoid breathing dust. P264 - Wash hands, forearms and face thoroughly after handling. P272 - Contaminated work clothing must not be allowed out of the workplace. P280 - Wear eye protection, protective gloves and clothing. P284 - In case of inadequate ventilation wear respiratory protection. P302+P352 - If on skin: Wash with plenty of soap and water. P304+P340 - If inhaled: Remove person to fresh air and keep at rest in a position comfortable for breathing. P305+P351+P338 - If in eyes: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P321 - Specific treatment (see Section 4 of this Safety Data Sheet on this label). P333+P313 - If skin irritation or rash occurs: Get medical advice or attention. P337+P313 - If eye irritation persists: Get medical advice or attention. P342+P311 - If experiencing respiratory symptoms: Call a poison center or doctor. P362+P364 - Take off contaminated clothing and wash it before reuse. P501 - Dispose of contents and/or container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulations. Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. Proper grounding procedures to avoid static electricity should be followed. Prevent dust accumulation (to minimize explosion hazard). Avoid generating dust. 2.3 Hazards associated with known or reasonably anticipated uses This product is a pharmaceutical product designed for administration to a patient by a qualified medical professional. No other uses are anticipated A Process Hazard Analysis (PHA) or other hazard assessment for additional specific end uses should be performed to ensure that hazards are fully understood, and adequate safety measures are in place. See Section 10 for relevant reactivity and stability information.

Other hazards

Exposure may aggravate pre-existing eye, skin, or respiratory conditions

Ingredient(s) with unknown acute toxicity

No data available

2.1 Classification of the substance or mixture

GHS-US Classification Serious eye damage/eye irritation, Category 2A H319 Respiratory sensitization, Category 1 H334 Skin sensitization, Category 1 H317 Combustible dust